Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Frontiers in Bioengineering and Biotechnology
|
July 18, 2022
Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions
Harish Sudarsanam, Raymund Buhmann, Reinhard Henschler
Experimental Cell Research
|
May 29, 2016
Inhibitory effect of extracellular purine nucleotide and nucleoside concentrations on T cell proliferation
Monica Weiler, Helga Schmetzer, Marion Braeu, et al.
Applied Microbiology and Biotechnology
|
November 12, 2005
Aptamers--basic research, drug development, and clinical applications
Daniela Proske, Michael Blank, Raymund Buhmann, et al.
Immunobiology
|
August 14, 2012
A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia
Ting Yang, Zhi-zhe Chen, Hans-Jochem Kolb, et al.
Hematology (Amsterdam, Netherlands)
|
September 29, 2005
DLI: where are we know?
Hans-Jochem Kolb, Christoph Schmid, Raymund Buhmann, et al.
Stem Cells International
|
February 7, 2017
Kindlin-2 Modulates the Survival, Differentiation, and Migration of Induced Pluripotent Cell-Derived Mesenchymal Stromal Cells
Mohsen Moslem, Reto Eggenschwiler, Christian Wichmann, et al.
The Journal of Infectious Diseases
|
February 1, 2022
Antibody Course and Memory B-Cell Response in the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Judith Kannenberg, Henning Trawinski, Reinhard Henschler, et al.
Journal of Translational Medicine
|
July 3, 2013
Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
Raymund Buhmann, Stanglmaier Michael, Hess Juergen, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery
Nina Deppisch, Peter Ruf, Nina Eissler, et al.
BMJ Open Sport & Exercise Medicine
|
July 19, 2018
Changes in the microRNA expression profile during blood storage
Anna Haberberger, Benedikt Kirchner, Irmgard Riedmaier, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Frontiers in Bioengineering and Biotechnology
|
July 18, 2022
Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions
Harish Sudarsanam, Raymund Buhmann, Reinhard Henschler
Experimental Cell Research
|
May 29, 2016
Inhibitory effect of extracellular purine nucleotide and nucleoside concentrations on T cell proliferation
Monica Weiler, Helga Schmetzer, Marion Braeu, et al.
Applied Microbiology and Biotechnology
|
November 12, 2005
Aptamers--basic research, drug development, and clinical applications
Daniela Proske, Michael Blank, Raymund Buhmann, et al.
Immunobiology
|
August 14, 2012
A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia
Ting Yang, Zhi-zhe Chen, Hans-Jochem Kolb, et al.
Hematology (Amsterdam, Netherlands)
|
September 29, 2005
DLI: where are we know?
Hans-Jochem Kolb, Christoph Schmid, Raymund Buhmann, et al.
Stem Cells International
|
February 7, 2017
Kindlin-2 Modulates the Survival, Differentiation, and Migration of Induced Pluripotent Cell-Derived Mesenchymal Stromal Cells
Mohsen Moslem, Reto Eggenschwiler, Christian Wichmann, et al.
The Journal of Infectious Diseases
|
February 1, 2022
Antibody Course and Memory B-Cell Response in the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Judith Kannenberg, Henning Trawinski, Reinhard Henschler, et al.
Journal of Translational Medicine
|
July 3, 2013
Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
Raymund Buhmann, Stanglmaier Michael, Hess Juergen, et al.
Molecular Cancer Therapeutics
|
June 12, 2015
Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery
Nina Deppisch, Peter Ruf, Nina Eissler, et al.
BMJ Open Sport & Exercise Medicine
|
July 19, 2018
Changes in the microRNA expression profile during blood storage
Anna Haberberger, Benedikt Kirchner, Irmgard Riedmaier, et al.
Page
of 3